BioXcel Therapeutics, Inc. (DUS:BX20) IPO
IPO
Priced at US$11.00 a share on Mar 7, 2018.
- Price
- US$11.00 a share
- Shares offered
- 5,454,545 shares of common stock
- Offering size
- US$60 million
- Underwriters' option
- Up to 818,181 more shares
- Listing
- BTAI on the Nasdaq Capital Market
- Underwriters
- Barclays, UBS Investment Bank, BMO Capital Markets, Canaccord Genuity · In the order on the cover
- Shares delivered
- On or about Mar 12, 2018
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 13, 2017 |
| Filed publicly | Feb 12, 2018 |
| Amended 3 times | Newest Mar 5, 2018 |
| Shares registered with an exchange | Mar 5, 2018 |
| Declared effective by the SEC | Mar 7, 2018 |
| Final prospectus, with the price | Mar 9, 2018 |
Filings
From the cover of the final prospectus (424B4) filed Mar 9, 2018